Novartis Basic registration template

First Page		Document Content
Clinical research Food and Drug Administration Pharmaceutical industry Everolimus Neuroendocrine tumor Renal cell carcinoma Response Evaluation Criteria in Solid Tumors Novartis Sirolimus Medicine Immunosuppressants Macrolides		Novartis Basic registration template Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,56 MB Share Document on Facebook

	“New Paradigms That Increase Survival in Neuroendocrine Tumor Patients” Eugene A. Woltering MD FACS NOLANETSZEBRA = office DocID: 1v5gL - View Document
	ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D DocID: 1rlNJ - View Document
	J. Vet. Med. A 36, 1989 Paul Parey Scientific Publishers, Berlin and Hamburg ISSN184X Department of Veterinary Pathology2, University of Utrecht, The Netherlands, Department of Veterinary Patholo DocID: 1r81K - View Document
	ORIGINAL ARTICLE Validation of Neurokinin A Assays in the United States and Europe Paris Mamikunian,* Joy E. Ardill, PhD,Þ Thomas M. O’Dorisio, MD,þ Siegfried R. Krutzik, PhD,* Aaron I. Vinik, MD, PhD,§ Vay Liang W DocID: 1r2MN - View Document
	JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide DocID: 1qMJM - View Document